Tovinontrine (CRD-750)

DRUG2 trials

Sponsors

Cardurion Pharmaceuticals, Inc.

Conditions

Cardiovascular DiseasesHeart DiseasesHeart FailureHeart Failure Preserved Ejection FractionHeart Failure With Reduced Ejection Fraction

Phase 2

Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Preserved Ejection Fraction (Cycle-2-PEF)

CompletedNCT06215586

Cardurion Pharmaceuticals, Inc.Cardiovascular Diseases, Heart Diseases, Heart Failure +1

Start: 2024-02-13End: 2025-09-02Updated: 2026-09-01

A Study to Assess Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Reduced Ejection Fraction (Cycle-1-REF)

CompletedNCT06215911

Cardurion Pharmaceuticals, Inc.Cardiovascular Diseases, Heart Diseases, Heart Failure +1

Start: 2024-02-13End: 2025-10-10Updated: 2026-09-01